Trial Profile
A real-life setting to evaluate the pharmacokinetics characteristics of dolutegravir
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Dec 2016
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Abacavir; Atazanavir; Darunavir; Emtricitabine; Etravirine; Rilpivirine
- Indications HIV infections
- Focus Pharmacokinetics
- 29 Dec 2016 New trial record